Wedbush Reiterates Outperform on Aprea Therapeutics, Raises PT to $7

Tuesday, Mar 31, 2026 10:19 am ET1min read
APRE--

Wedbush Reiterates Outperform on Aprea Therapeutics, Raises PT to $7

Wedbush Reiterates Outperform on Aprea Therapeutics, Raises PT to $7

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet